[Progress in the Study of Mechanisms Clinically Relevant to Insulin Resistance and Lung Cancer] [0.03%]
[有关胰岛素抵抗和肺癌的临床相关机制研究进展]
Xiaoyu Chen,Peng Chen
Xiaoyu Chen
At present, the incidence and mortality rates of lung cancer rank top among malignant tumors. The early diagnosis, treatment and drug resistance of lung cancer still remain as problems in the management of lung cancer. Researchers are dedic...
[Real-world Study of the Safety and Efficacy of Pembrolizumab in the Treatment of Advanced Non-small Cell Lung Cancer] [0.03%]
派姆单抗治疗晚期非小细胞肺癌安全性和有效性的真实世界研究
Ning Wan,Bing Wang,Ya Guo et al.
Ning Wan et al.
Background: Pembrolizumab (PEM) has been shown to be effective in clinical trials for the treatment of advanced non-small cell lung cancer (NSCLC), but clinical trials were based on cohorts of patients selected on specifi...
[GINS1 Enhances Glycolysis, Proliferation and Metastasis in Lung Adenocarcinoma Cells by Activating the Notch/PI3K/AKT/mTORC1 Signaling Pathway] [0.03%]
[GINS1通过激活Notch/PI3K/AKT/mTORC1信号通路增强肺腺癌细胞的糖酵解、增殖和转移]
Yishan Huo,Xiaohui Xu,Xiumin Ma et al.
Yishan Huo et al.
Background: Lung cancer is the most common type of cancer, accounting for more than half of all cancer cases, with lung adenocarcinoma (LUAD) representing over half of lung cancer patients. Currently, the 5-year survival ...
[Non-targeted Metabolomics-based Exploration of Radiation-induced Metabolic Alterations in Mouse Lung Epithelial Cells] [0.03%]
基于非靶向代谢组学的辐射诱导的小鼠肺上皮细胞代谢改变研究
Hao Fan,Xiangwei Ge,Xin Zhou et al.
Hao Fan et al.
Background: Metabolic change is one of the important characteristics of radiation pneumonitis. Radiotherapy, as a conventional method for the treatment of thoracic tumors, can not only effectively kill tumor cells, but al...
[Extracorporeal Membrane Oxygenation in Complex Tracheobronchial Surgery: A Series Case Reports and Systematic Review] [0.03%]
复杂气管支气管手术中体外膜肺氧合的应用：病例报告与系统综述
Chen Shu,Peilong Bao,Yunfeng Ni et al.
Chen Shu et al.
Airway management in complex tracheobronchial surgery (TBS) remains a challenge in thoracic surgery. The use of extracorporeal membrane pulmonary oxygenation (ECMO) in thoracic surgery is rather rare, except for lung transplantation. To rep...
[Bronchoscopic Interventional Treatment of Mixed Squamous Cell and Glandular Papilloma of Diffuse Trachea: A Case Report and Literature Review] [0.03%]
支气管镜介入治疗弥漫性气管混合型鳞状细胞腺样乳头状瘤一例及相关文献复习
Xiaosen Huo,Yao Zhang,Yanyan Dong et al.
Xiaosen Huo et al.
Pulmonary mixed squamous cell and glandular papilloma (MSCGP) is a subtype of pulmonary papilloma, which can be classified as central type and peripheral type based on its site of development. The central type is the most common. The clinic...
Lishan Peng,Wenzhao Zhong
Lishan Peng
Non-small cell lung cancer (NSCLC) is one of the most prevalent and deadliest cancers worldwide. While the use of targeted therapies and immunotherapies in precision medicine has improved outcomes for some patients, a significant portion of...
[Research Progress on the Mechanism and Diagnostic Markers of Bone Metastasis in Small Cell Lung Cancer] [0.03%]
小细胞肺癌骨转移机制及诊断标志物研究进展
Xingyu Xiang,Yandong Nan
Xingyu Xiang
Small cell lung cancer (SCLC) is a type of lung cancer with high malignant degree, rapid transformation, rapid invasion and metastasis, which is prone to early metastasis and poor prognosis. Bone metastases of SCLC occur in three stages: ca...
[Research Progress of Comprehensive Follow-up Management Strategy on the Natural History of Simultaneous, Persistent Multiple Pulmonary Ground-glass Nodules] [0.03%]
[同时持续性多发肺磨玻璃结节自然史的综合随访管理策略研究进展]
Chengming Huang,Yongzhao Zhou,Yujin Fang et al.
Chengming Huang et al.
The development and change patterns as well as the disease course management of multiple ground-glass nodules (GGNs) in the lungs are currently hotspots and difficulties in clinical lung cancer research. Understanding the latest advancement...
[Advances on Molecular Mechanism and Clinical Treatment in Invasive Mucinous Adenocarcinoma] [0.03%]
侵袭性黏液腺癌分子机制及临床治疗进展
Minjun Shi,Bo Ye
Minjun Shi
Invasive mucinous adenocarcinoma (IMA) is a special type of lung adenocarcinoma that accounts for 2% to 10% of all lung adenocarcinoma. Surgical treatment is preferred for IMA, and traditional chemotherapy drugs and targeted therapy drugs h...